Taizhou, China

Yi Zhang

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Zhejiang Tianyu Pharmaceutical Co., Ltd.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Zhang. Retrieved from https://idiyas.com/inventor/yi-zhang-s7typ2hq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yi Zhang - Innovator in Pharmaceutical Chemistry

Introduction

Yi Zhang is a prominent inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important compounds.

Latest Patents

Yi Zhang holds a patent for a method for preparing Aliskiren and its intermediates. This innovative method involves several steps, including the reaction of 4-bromo-1-methoxy-2-(3-methoxypropoxy)benzene with magnesium isopropyl chloride and n-BuLi to obtain a specific compound. The process continues with the methylsulfonylation of the compound and subsequent reactions to yield Aliskiren.

Career Highlights

Yi Zhang is associated with Zhejiang Tianyu Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His work has led to advancements in the synthesis of vital medications, showcasing his commitment to improving healthcare through innovation.

Collaborations

He has collaborated with notable colleagues, including Yongjun Tu and Rongde Cheng, to further enhance the research and development efforts within his company.

Conclusion

Yi Zhang's contributions to pharmaceutical chemistry and his innovative methods for synthesizing Aliskiren highlight his role as a key inventor in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…